TCBPW Accounts Payable from 2010 to 2025

TCBPW Stock  USD 0.01  0  18.67%   
TC BioPharm Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 1.2 M in 2025. Accounts Payable is the amount TC BioPharm plc owes to suppliers or vendors for products or services received but not yet paid for. It represents TC BioPharm's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
2.1 M
Current Value
1.2 M
Quarterly Volatility
487.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check TC BioPharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TC BioPharm's main balance sheet or income statement drivers, such as Interest Income of 1.9 K, Depreciation And Amortization of 638 K or Interest Expense of 90.7 K, as well as many indicators such as Price To Sales Ratio of 9.94, Dividend Yield of 0.0 or PTB Ratio of 4.34. TCBPW financial statements analysis is a perfect complement when working with TC BioPharm Valuation or Volatility modules.
  
Check out the analysis of TC BioPharm Correlation against competitors.

Latest TC BioPharm's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of TC BioPharm plc over the last few years. An accounting item on the balance sheet that represents TC BioPharm obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of TC BioPharm plc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. TC BioPharm's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TC BioPharm's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

TCBPW Accounts Payable Regression Statistics

Arithmetic Mean899,134
Geometric Mean812,003
Coefficient Of Variation54.21
Mean Deviation373,693
Median627,933
Standard Deviation487,412
Sample Variance237.6B
Range1.5M
R-Value0.71
Mean Square Error127.2B
R-Squared0.50
Significance0
Slope72,399
Total Sum of Squares3.6T

TCBPW Accounts Payable History

20251.2 M
20242.1 M
20231.8 M
2022882.4 K
20211.4 M
2020638.4 K

About TC BioPharm Financial Statements

TC BioPharm investors use historical fundamental indicators, such as TC BioPharm's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TC BioPharm. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable2.1 M1.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TCBPW Stock Analysis

When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.